Acasti Pharma Inc (NASDAQ:ACST)

Delayed Data
As of Jun 21
 +0.0392 / +5.52%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 4.30, with a high estimate of 5.47 and a low estimate of 3.13. The median estimate represents a +473.48% increase from the last price of 0.75.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jun 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 27.50%
Growthannually -25.05%


Growthquarterly --
Growthannually 28.11%
Key to the earnings and sales forecast charts.